Display options
Share it on

Mol Cytogenet. 2015 Sep 02;8:70. doi: 10.1186/s13039-015-0172-1. eCollection 2015.

A cryptic balanced translocation (5;17), a puzzle revealed through a critical evaluation of the pedigree and a FISH focused on candidate loci suggested by the phenotype.

Molecular cytogenetics

A Primerano, E Colao, C Villella, M D Nocera, A Ciambrone, E Luciano, L D'Antona, M F M Vismara, S Loddo, A Novelli, N Perrotti, Paola Malatesta

Affiliations

  1. Unit of Medical Gentics, University Hospital Mater Domini, Catanzaro, Italy.
  2. Department of "Scienze della Salute", Università UMG di Catanzaro, Catanzaro, Italy.
  3. Mendel Laboratory, Casa Sollievo della Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy.
  4. Genetics Unit, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.

PMID: 26336513 PMCID: PMC4557763 DOI: 10.1186/s13039-015-0172-1

Abstract

We report a case of a woman with a cryptic balanced translocation between chromosomes 5 and 17, suspected during genetic counseling. The woman had a history of previous fetal losses attributed to lissencephaly and intra uterine growth retardation (IUGR) and a daughter with dysmorphic features and mental retardation, previously attributed to a small deletion 5pter, detected years ago by a first generation CGH-array. This peculiar combination of personal and family history suggested the opportunity to carry out a FISH approach, focusing on chromosomes 5 and 17, based on the idea that a malsegregation secondary to a balanced translocation, might have escaped the first CGH array. This approach allowed the identification of a balanced translocation in the mother, FISH in the affected child confirmed the partial 5p deletion predicted by the previous CGH array and identified a new 17p duplication that had not been detected before. The described translocation opens the possibility of alternative imbalances that were probably responsible for previous fetal losses. The imbalances were confirmed by a new high resolution SNP array. We conclude that despite the availability of highly effective and sensitive genomic approaches a careful evaluation of medical history is highly recommended since it can suggest clinical hypothesis that can be confirmed by more classical and molecular cytogenetic based approaches.

References

  1. Eur J Med Genet. 2011 May-Jun;54(3):287-91 - PubMed
  2. Am J Hum Genet. 1995 Jun;56(6):1404-10 - PubMed
  3. J Hum Genet. 2005;50(1):26-9 - PubMed
  4. Mol Cytogenet. 2014 Nov 19;7(1):82 - PubMed
  5. Orphanet J Rare Dis. 2006 Sep 05;1:33 - PubMed
  6. Am J Hum Genet. 2005 Feb;76(2):312-26 - PubMed
  7. Hum Genet. 1978 Nov 16;44(3):227-75 - PubMed
  8. Eur J Med Genet. 2006 Jan-Feb;49(1):87-92 - PubMed
  9. Am J Med Genet A. 2011 Apr;155A(4):875-9 - PubMed
  10. Eur J Med Genet. 2014 Mar;57(4):145-50 - PubMed
  11. Mol Syndromol. 2012 Aug;3(2):82-8 - PubMed
  12. J Med Genet. 2009 Oct;46(10):703-10 - PubMed
  13. Child Dev. 2013 Jan-Feb;84(1):121-32 - PubMed
  14. Am J Med Genet A. 2013 Aug;161A(8):1833-52 - PubMed
  15. Am J Med Genet. 2000 Jan 31;90(3):203-15 - PubMed
  16. Am J Med Genet A. 2005 Mar 1;133A(2):189-92 - PubMed
  17. Nat Genet. 2009 Feb;41(2):168-77 - PubMed
  18. Case Rep Genet. 2013;2013:573841 - PubMed
  19. Am J Hum Genet. 2003 Apr;72(4):940-8 - PubMed
  20. J Med Genet. 1999 Jul;36(7):567-70 - PubMed
  21. J Med Genet. 2010 May;47(5):299-311 - PubMed
  22. Am J Hum Genet. 1995 May;56(5):1162-72 - PubMed
  23. Eur J Hum Genet. 2005 Apr;13(4):475-85 - PubMed

Publication Types